Press Releases

DURHAM, NC, and LIEGE, BELGIUM - May 27, 2010,10:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today that its Belgium based clinical diagnostics service laboratory has received the important ISO 9001:2008...

Read More...

Durham (NC, USA) and Liege (Belgium) - May 12, 2010, 18:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) reports that it received a transparency statement which shows that on May 6, 2010, Drs. Herman Spolders reduced his shareholding in the company from 3.28...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - May 6, 2010, 8:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company in the field of cancer and pharmacogenomics, today issued its Q1 2010 business update, providing an overview of financial...

Read More...

* { font-family: Arial, Verdana, Helvetica; font-size: 13px;} td { padding: 3px; } }DURHAM, NC, and LIEGE, BELGIUM - May 3, 2010, 8:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, presented an update on its blood-based...

Read More...

Liege (Belgium) - April 12, 2010, 8:00 CET - OncoMethylome Sciences SA announced today that its board of directors has named Dr. Jan Groen to serve as the company's chief executive officer.  The company also reports that all agenda items for the Extraordinary General Shareholders' meeting held...

Read More...

Liège (Belgium) - March 11, 2010, 7:00 AM CET - OncoMethylome Sciences SA publishes its financial results for the period ended December 31, 2009.   2009 operational highlights:   Starting at the end of 2009, OncoMethylome focused its R&D efforts on four core areas: colorectal cancer...

Read More...

Liege (Belgium) - February 12, 2010, 8:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) reports that it received a transparency statement which shows that on February 3, 2010, APG Algemene Pensioen Groep NV held 559,102 shares (or 4.24%) of the total 13,185,...

Read More...

OncoMethylome's Technology is being used in Roche Clinical Trial Program with Avastin   Liege (Belgium) - January 6, 2010, 8:00 AM CET - OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) announced today that it has entered into an agreement with F. Hoffmann...

Read More...

Liege (Belgium) - November 5, 2009, 8:00 AM CET - OncoMethylome Sciences announces today its third quarter financial results, the focusing of the business, an update on the status of certain of its products, and a change in management.   Q3 2009 material events   Published new clinical...

Read More...

Shareholder Notification   Liege (Belgium) - October 29, 2009, 8:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) announces today that it has received the following shareholder notification covering changes to the Transparency Declaration of the Company...

Read More...

Pages